Preparation method and application of medicine for treating abdominal adhesion

By using ethanol extraction and emulsification of Panax notoginseng, radish seed, and black sesame, the problem of poor treatment effect of abdominal adhesions has been solved, providing a safe and effective traditional Chinese medicine composition that reduces side effects and improves bioavailability.

CN118987070APending Publication Date: 2024-11-22新疆医科大学第四附属医院
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411155793.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing technologies are ineffective and have significant side effects in treating abdominal adhesions, and there is a lack of safe and effective traditional Chinese medicine compositions.

Method used

Using Panax notoginseng, radish seed, and black sesame as the main ingredients, an emulsion is prepared by ethanol extraction and emulsifier to improve bioavailability and therapeutic effect.

Benefits of technology

It significantly reduces abdominal adhesions in rats, reduces the side effects of chemical drugs, and improves patient compliance, demonstrating potential for clinical application.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a preparation method and application of a medicine for treating abdominal adhesion, and belongs to the technical field of traditional Chinese medicines. The invention discloses a medicine for treating abdominal adhesion. The medicine comprises an ethanol extract of a traditional Chinese medicine composition and an emulsifier, the traditional Chinese medicine composition comprises pseudo-ginseng, semen raphani and black sesame. The invention also provides an application of the ethanol extract and emulsifier of the traditional Chinese medicine composition in preparation of drugs for treating abdominal adhesion of rats. Results show that the ethanol extract and the emulsifier of the traditional Chinese medicine composition provided by the invention have a remarkable treatment effect on abdominal adhesion of rats. Therefore, the ethanol extract and the emulsifier of the traditional Chinese medicine composition disclosed by the invention have certain development and application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicines, and in particular to a preparation method and application of a medicine for treating abdominal adhesion. Background Art

[0002] In the intersection of traditional medicine and modern pharmacology, Chinese medicine has shown great potential in treating a variety of diseases due to its unique mechanism of action and fewer side effects. In recent years, with the advancement of science and technology, the modernization and internationalization of Chinese medicine has become a research hotspot, especially in the search for new treatment methods to deal with intractable diseases, the in-depth development of Chinese medicine is particularly important.

[0003] Abdominal adhesions, as a common complication after abdominal surgery, bring long-term pain to patients, such as recurrent abdominal pain, female infertility and possible intestinal obstruction, which seriously affects the quality of life of patients. At present, there are limited methods for preventing or treating abdominal adhesions in clinical practice, and most of them are accompanied by obvious side effects or poor effects. Therefore, exploring safe and effective natural medicines or Chinese medicine combinations has become the key to alleviating this medical problem. Therefore, developing a new Chinese medicine formula for the prevention and treatment of rat abdominal adhesions is not only a continuation and innovation of the wisdom of traditional Chinese medicine, but also provides new ideas and possibilities for solving practical clinical problems, which has important scientific significance and clinical application value. Summary of the invention

[0004] The purpose of the present invention is to provide a preparation method and application of a drug for treating abdominal adhesions, so as to solve the problems existing in the above-mentioned prior art. The drug provided by the present invention has a significant therapeutic effect on rats with abdominal adhesions and has a certain development and application prospect.

[0005] To achieve the above object, the present invention provides the following solutions:

[0006] Technical solution 1: A medicine for treating abdominal adhesion, the components of the medicine include an ethanol extract of a traditional Chinese medicine composition and an emulsifier; the components of the traditional Chinese medicine composition include Panax notoginseng, radish seeds and black sesame.

[0007] Furthermore, in terms of weight, the components of the Chinese medicine composition include: 30-45 parts of Panax notoginseng, 20-35 parts of radish seeds, and 20-35 parts of black sesame.

[0008] Furthermore, calculated by weight, the components of the Chinese medicine composition include: 35 parts of Panax notoginseng, 25 parts of radish seeds, and 20 parts of black sesame.

[0009] Furthermore, the preparation method of the ethanol extract comprises: crushing each Chinese medicine in the Chinese medicine composition into coarse powder, adding 15 times the amount of ethanol, and soaking for 10 days, wherein the volume concentration of the ethanol is 90%.

[0010] Furthermore, the emulsifier is poloxamer.

[0011] Furthermore, after filtering the ethanol extract, sterile distilled water was diluted to an ethanol content of 50%, and mixed with the emulsifier in a volume ratio of 10:1, ultrasonicated at 350w for 10min, emulsified 3 times under 1500bar, and centrifuged at 4000r / min for 5min to obtain the drug without stratification.

[0012] Technical solution 2: Use of the drug in preparing a drug for treating abdominal adhesions in rats.

[0013] The present invention discloses the following technical effects:

[0014] The present invention discloses a preparation method and application of a drug for treating abdominal adhesion. The present invention is a new type of medicament developed based on the theory of traditional Chinese medicine, aiming to enhance the bioavailability and therapeutic effect of Chinese medicine ingredients through modern preparation technology. Its main ingredients include: Panax notoginseng: Panax notoginseng, also known as Panax notoginseng, is the dried root and rhizome of Panax notoginseng of the Araliaceae family, rich in saponins, polysaccharides, flavonoids and other active ingredients, has the effects of promoting blood circulation and removing blood stasis, reducing swelling and relieving pain, and is widely used in the treatment of cardiovascular system diseases and trauma. Radish seeds: Radish seeds are the mature seeds of the cruciferous plant radish, which have the effects of digesting food and removing bloating, lowering qi and removing phlegm, and can be used to treat symptoms such as food accumulation and qi stagnation, cough and sputum. It contains fatty oil, protein, multiple vitamins and trace elements, which can promote digestion and improve gastrointestinal function. Black sesame: Black sesame is the black seed of the plant Sesame of the Pedaliaceae family. It is rich in nutrients such as fatty oil, protein, calcium, and iron. Chinese medicine believes that it has the effects of nourishing the liver and kidney, moistening the intestines and relieving constipation, and blackening hair and nourishing the skin. It is suitable for liver and kidney deficiency, premature graying of hair, constipation, etc. The present invention extracts these three Chinese medicinal ingredients with ethanol to effectively extract the active ingredients therein. Ethanol as a solvent can better dissolve the fat-soluble components in the Chinese medicine and improve the extraction efficiency. Subsequently, the Chinese medicine extract is made into an emulsion form by adding an emulsifier. The emulsion can increase the stability of the drug, facilitate oral absorption, and improve bioavailability. It can also cover up the bad smell and improve the patient's compliance with medication.

[0015] The present invention proposes the use of the drug in treating abdominal adhesions in rats. Abdominal adhesions are a common complication that usually occurs after abdominal surgery and can cause serious consequences such as pain and intestinal obstruction. The present invention uses this drug to conduct animal experiments to explore its potential for preventing or treating abdominal adhesions, reflecting the direction of modern research on traditional Chinese medicine, that is, to scientifically verify the efficacy of traditional Chinese medicine and develop new uses for it in the treatment of specific diseases. This new formulation technology based on traditional Chinese medicine is expected to provide safer and more effective treatment options for clinical practice, reduce the side effects of chemical drugs, conform to the current trend of medical development, and have certain development and application prospects. DETAILED DESCRIPTION

[0016] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.

[0017] It should be understood that the terms described in the present invention are only for describing a particular embodiment and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. The intermediate value in any stated value or stated range, and each smaller range between any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.

[0018] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.

[0019] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to those skilled in the art. The present invention description and examples are exemplary only.

[0020] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.

[0021] Example 1

[0022] A preparation method of a medicine for treating abdominal adhesion

[0023] 35 parts of Panax notoginseng, 25 parts of Radish seeds and 20 parts of black sesame are crushed into coarse powder, mixed and then added with 15 times the amount of ethanol, and soaked for 10 days, with the volume concentration of ethanol being 90%. The obtained ethanol extract is filtered, diluted with sterile distilled water to an ethanol content of 50%, mixed with poloxamer at a volume ratio of 10:1, ultrasonicated at 350W for 10 minutes, emulsified 3 times at 1500bar, centrifuged at 4000r / min for 5 minutes, and obtained without stratification.

[0024] Example 2

[0025] A preparation method of a medicine for treating abdominal adhesion

[0026] 30 parts of Panax notoginseng, 20 parts of radish seeds and 25 parts of black sesame are crushed into coarse powder, mixed and then added with 15 times the amount of ethanol, and soaked for 10 days, with the volume concentration of ethanol being 90%. The obtained ethanol extract is filtered, diluted with sterile distilled water to an ethanol content of 50%, mixed with poloxamer at a volume ratio of 10:1, ultrasonicated at 350W for 10 minutes, emulsified 3 times at 1500bar, centrifuged at 4000r / min for 5 minutes, and obtained without stratification.

[0027] Example 3

[0028] A preparation method of a medicine for treating abdominal adhesion

[0029] 45 parts of Panax notoginseng, 35 parts of Radish seeds and 35 parts of black sesame are crushed into coarse powder, mixed and then added with 15 times the amount of ethanol, and soaked for 10 days, with the volume concentration of ethanol being 90%. The obtained ethanol extract is filtered, diluted with sterile distilled water to an ethanol content of 50%, mixed with poloxamer at a volume ratio of 10:1, ultrasonicated at 350W for 10 minutes, emulsified 3 times at 1500bar, centrifuged at 4000r / min for 5 minutes, and obtained without stratification.

[0030] Example 4

[0031] 1. Drug safety evaluation

[0032] The drug prepared in Example 1 was subjected to acute oral experiment on mice. Method: 10 mice were given 0.8 ml of the drug by gavage at the maximum dose at one time, and 1.2 ml of the drug was given 24 hours later, and no mouse death was observed; Skin irritation experiment: The drug of the present invention was applied to the back skin of rabbits, and no biting, scratching, and redness and swelling were observed in the rabbits, indicating that the drug prepared in the present invention does not cause irritation to the skin.

[0033] Example 5

[0034] 1. The therapeutic effect of drugs on abdominal adhesion in rats

[0035] Male SD rats (200-230g) were selected to establish a rat cecum-abdominal wall adhesion model. The rats were fasted and deprived of water for 12 hours, and anesthetized with 4% chloral hydrate by intraperitoneal injection. The abdominal hair was shaved and disinfected. Then a 4-5 cm long incision was made along the midline of the abdominal wall with surgical scissors. The cecum was separated and its serosal surface was gently rubbed with sterile surgical gauze until punctate bleeding appeared. A 1cm×2cm peritoneal defect was created on the corresponding side of the abdominal wall with a scalpel. After treating the cecum and abdominal injury sites, the cecum was returned to the abdominal cavity and the abdomen was sutured and closed. The animals were kept in single cages after surgery and observed every day. Intraperitoneal anesthesia was performed 7 and 14 days after surgery, the abdomen was carefully opened, the adhesion was observed and scored.

[0036] SD rats were divided into four groups, with 10 rats in each group: the first group was a normal saline control group, and 1 mL of normal saline was injected into the injured part for treatment; the second group was an experimental group of Example 1, and 1 mL of drug was injected into the injured part for treatment; the third group was an experimental group of Example 2, and 1 mL of drug was injected into the injured part for treatment; the fourth group was an experimental group of Example 3, and 1 mL of drug was injected into the injured part for treatment.

[0037] On the 7th and 14th days after surgery, the rats were anesthetized by intraperitoneal injection of chloral hydrate, and the abdomen was carefully opened to observe the abdominal adhesions and score the adhesions according to the international standard adhesion scoring method: 0 point, no adhesion; 1 point, one thin adhesion; 2 points, more than one adhesion; 3 points, relatively tight adhesion; 4 points, more than one tight adhesion; 5 points, large area of ​​vascularized adhesion.

[0038] The adhesion results showed that on the 7th day after surgery, the adhesion in the normal saline control group was serious, and no adhesion occurred in the experimental group of Examples 1-3. The results on the 14th day after surgery were similar to those on the 7th day, and the abdominal adhesion of each group of rats was scored. The adhesion score of the normal saline control group was close to 4 points, and the adhesion score of the experimental group of Examples 1-3 was close to 0 points. The results show that the drug of the present invention has a therapeutic effect on abdominal adhesion in rats.

[0039] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.

Claims

1. A drug for treating abdominal adhesion, characterized in that: The components of the medicine include ethanol extract of a traditional Chinese medicine composition and an emulsifier; the components of the traditional Chinese medicine composition include notoginseng, radish seeds and black sesame.

2. The drug according to claim 1, characterized in that Calculated by weight, the components of the traditional Chinese medicine composition include: 30-45 parts of Panax notoginseng, 20-35 parts of radish seeds, and 20-35 parts of black sesame.

3. The drug according to claim 2, characterized in that Calculated by weight, the components of the traditional Chinese medicine composition include: 35 parts of Panax notoginseng, 25 parts of radish seeds, and 20 parts of black sesame.

4. The drug according to claim 1, characterized in that The preparation method of the ethanol extract comprises: crushing each Chinese medicine in the Chinese medicine composition into coarse powder, adding 15 times the amount of ethanol, and soaking for 10 days, wherein the volume concentration of the ethanol is 90%.

5. The drug according to claim 1, characterized in that The emulsifier is poloxamer.

6. The method for preparing the drug according to claim 1, characterized in that: After filtering the ethanol extract, dilute it with sterile distilled water to an ethanol content of 50%, mix it with the emulsifier at a volume ratio of 10:1, ultrasonicate it at 350w for 10min, emulsify it 3 times at 1500bar, centrifuge it at 4000r / min for 5min, and obtain the drug without stratification.

7. Use of the drug according to any one of claims 1 to 5 in the preparation of a drug for treating abdominal adhesion in rats.

Citation Information

Patent Citations

  • Surgical anti-adhesion flushing liquid

    CN102552120A

  • Application of centipede pseudo-ginseng extract product in preparation of medicine against intestinal adhesion and medicine thereof

    CN103381205A